BTF3 and liver cancer: It has been found that the expression of BTF3 is increased in a variety of cancers, including prostate, gastric (Zhang et al. 2017), breast (Ding et al. 2019; Wang et al. 2021), pancreatic (Kusumawidjaja et al. 2007), colorectal (Wang et al. 2020), and liver cancers (Roy et al. 2010).